NCT05455684: A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
- State
- Completed
- Phase
- Phase 3
- People
- 513 taking part
- Started
- 22 Jun 2022
- Primary completion
- 18 Sep 2024
- Arms
- Aticaprant
- Results
- Posted on the registry
- 22 Jun 2022: Trial started
- 13 Jul 2022: Trial registered
- 18 Sep 2024: Trial completed
- 6 Nov 2025: Trial results posted